Tag
This essay argues that slow and costly U.S. clinical trials—not scientific limitations—are now the biggest obstacle to curing cancer and deploying AI-driven personalized therapies, urging regulatory reform as China and Australia outpace American drug development.
Sam Altman tweets that physicians found fewer flaws in GPT-5.6 responses than in physician-written responses, signaling a significant leap for AI in healthcare.
The article covers recent AI developments including the release of Claude Opus 4.6, xAI joining SpaceX, AI outperforming doctors in medical tasks, and the push for standardized AI audits.
OpenAI assembled a team of practicing doctors to evaluate and improve ChatGPT's health-related responses using real clinical experience, aiming to enhance accuracy and communication methods, ultimately democratizing medical knowledge.